Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
19:13:44 EDT Mon 30 Jun 2025
Enter Symbol
or Name
USA
CA



Q:NKTX - NKARTA INC - Website unknown - click to update
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
NKTX - Q1.01.64·1.870.11.66505.17531,6821.68  1.70  1.648.23  1.3116:45:18Jun 0615 min RT 2¢

Recent Trades - Last 10 of 1682
Time ETExPriceChangeVolume
16:45:18Q1.66 28
16:10:06Q1.66 2
16:10:03Q1.66 1
16:04:14Q1.66 1
16:04:06Q1.66 1
16:03:21Q1.66 640
16:03:18Q1.66 320
16:02:38Q1.66 547
16:02:36Q1.66 346
16:02:22Q1.66 285

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-06-06 08:52U:NKTXNews ReleaseNkarta Appoints Shawn Rose Chief Medical Officer & Head of R&D as Company Resets Senior Leadership Role for Autoimmune Focus
2025-05-14 16:01U:NKTXNews ReleaseNkarta Reports First Quarter 2025 Financial Results and Corporate Highlights
2025-04-01 08:01U:NKTXNews ReleaseNkarta to Participate in an April Investor Conference
2025-03-26 16:01U:NKTXNews ReleaseNkarta Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Highlights
2025-02-25 08:01U:NKTXNews ReleaseNkarta to Participate in March Investor Conferences
2024-12-05 06:01U:NKTXNews ReleaseNkarta Announces IND Clearance of Investigator-Sponsored Trial in Myasthenia Gravis and Opening of Enrollment for Ntrust-2
2024-11-26 07:02U:NKTXNews ReleaseNkarta to Participate in an Upcoming Investor Conference
2024-11-12 08:02U:NKTXNews ReleaseNkarta to Participate in an Upcoming Investor Conference
2024-11-07 16:02U:NKTXNews ReleaseNkarta Reports Third Quarter 2024 Financial Results and Corporate Highlights
2024-09-03 16:01U:NKTXNews ReleaseNkarta to Participate in Upcoming Investor Conference
2024-08-13 21:04U:NKTXNews ReleaseCorrection: Nkarta Reports Second Quarter 2024 Financial Results and Corporate Highlights
2024-08-13 16:01U:NKTXNews ReleaseNkarta Reports Second Quarter 2024 Financial Results and Corporate Highlights
2024-07-24 06:00U:NKTXNews ReleaseNkarta Announces Initiation of Investigator-Sponsored Clinical Trial Evaluating NKX019 for Systemic Lupus Erythematosus
2024-07-16 06:01U:NKTXNews ReleaseNkarta Announces Leadership Updates, Appoints Nadir Mahmood as President